95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.84%
Positive revenue growth while RGLD is negative. John Neff might see a notable competitive edge here.
-5.28%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-0.35%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-0.35%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-86.91%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-86.84%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-86.84%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.19%
Share count expansion well above RGLD's 0.05%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.01%
Slight or no buyback while RGLD is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
17.11%
Dividend growth above 1.5x RGLD's 0.02%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
8.12%
OCF growth under 50% of RGLD's 26.60%. Michael Burry might suspect questionable revenue recognition or rising costs.
127.02%
FCF growth above 1.5x RGLD's 5.73%. David Dodd would verify if the firm’s strategic investments yield superior returns.
196.24%
Similar 10Y revenue/share CAGR to RGLD's 201.46%. Walter Schloss might see both firms benefiting from the same long-term demand.
7.88%
5Y revenue/share CAGR under 50% of RGLD's 31.95%. Michael Burry would suspect a significant competitive gap or product weakness.
24.99%
3Y revenue/share CAGR under 50% of RGLD's 101.85%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
192.99%
10Y OCF/share CAGR at 50-75% of RGLD's 379.20%. Martin Whitman might fear a structural deficiency in operational efficiency.
-14.53%
Negative 5Y OCF/share CAGR while RGLD is at 102.48%. Joel Greenblatt would question the firm’s operational model or cost structure.
13.51%
3Y OCF/share CAGR under 50% of RGLD's 100.16%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-77.12%
Negative 10Y net income/share CAGR while RGLD is at 80.41%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-93.99%
Negative 5Y net income/share CAGR while RGLD is 1.80%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-90.63%
Negative 3Y CAGR while RGLD is 162.06%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
285.20%
10Y equity/share CAGR at 75-90% of RGLD's 378.85%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
49.04%
5Y equity/share CAGR above 1.5x RGLD's 28.81%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
18.79%
Positive short-term equity growth while RGLD is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
-42.97%
Negative 5Y dividend/share CAGR while RGLD stands at 108.68%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-42.97%
Negative near-term dividend growth while RGLD invests at 14.92%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-20.14%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-100.00%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-2.73%
Negative asset growth while RGLD invests at 0.37%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-0.66%
We have a declining book value while RGLD shows 0.46%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-11.30%
We’re deleveraging while RGLD stands at 0.50%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-60.99%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.